España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Theravance Biopharma
TBPH
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$9.52
-0.05
-0.52%
At close: -
$9.55
0.03
0.32%
After Hours: Nov 15, 4:31 PM EDT
Get Report
Comment
Q3 2024 Earnings were released on Tue Nov 12th, after the market close
The most recent conference call was at 17:00 PM, 5 days ago
Click to view past webcast
Theravance Biopharma (TBPH) Forecast
News
Earnings
Theravance Biopharma (TBPH) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Theravance Biopharma (NASDAQ:TBPH) Stock
Theravance Biopharma Stock (NASDAQ: TBPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 13, 2024
Theravance Biopharma shares are trading highe...
Benzinga Newsdesk
Tuesday, November 12, 2024
Theravance Biopharma Sees FY24 R&D Expense $3...
Benzinga Newsdesk
Theravance Biopharma Q3 2024 Adj. EPS $(0.26)...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Friday, October 18, 2024
Theravance Publishes Sub-Study 12-Week, Rando...
Benzinga Newsdesk
Monday, September 16, 2024
Unveiling 4 Analyst Insights On Theravance Biopharma
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Therava...
Benzinga Newsdesk
Tuesday, August 06, 2024
Theravance Q2 Loss Wider Than Expected, Revenues Rise Y/Y
Zacks
HC Wainwright & Co. Maintains Buy on Theravan...
Benzinga Newsdesk
Theravance Biopharma shares are trading lower...
Benzinga Newsdesk
Cracking The Code: Understanding Analyst Reviews For Theravance Biopharma
Benzinga Insights
TD Cowen Maintains Hold on Theravance Biophar...
Benzinga Newsdesk
Leerink Partners Downgrades Theravance Biopha...
Benzinga Newsdesk
Monday, August 05, 2024
Theravance Biopharma Now Expects FY24 Levels ...
Benzinga Newsdesk
Theravance Biopharma Q2 2024 Adj. EPS $(0.13)...
Benzinga Newsdesk
Wednesday, June 12, 2024
Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Wednesday, May 29, 2024
HC Wainwright & Co. Reiterates Buy on Therava...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Buy on Therava...
Benzinga Newsdesk
Monday, May 13, 2024
Theravance Biopharma Q1 2024 GAAP EPS $(0.24)...
Benzinga Newsdesk
Friday, April 12, 2024
Theravance Biopharma shares are trading highe...
Benzinga Newsdesk
BTIG Initiates Coverage On Theravance Biophar...
Benzinga Newsdesk
Monday, February 26, 2024
Theravance Biopharma Expects Non-GAAP Loss In...
Benzinga Newsdesk
Recap: Theravance Biopharma Q4 Earnings
Benzinga Insights
Theravance Biopharma Q4 2023 GAAP EPS $(0.17)...
Benzinga Newsdesk
Earnings Scheduled For February 26, 2024
Benzinga Insights
Friday, February 23, 2024
A Preview Of Theravance Biopharma's Earnings
Benzinga Insights
Tuesday, January 23, 2024
Logitech Posts Q3 Results, Joins Coinbase And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
Tuesday, January 16, 2024
On January 12, 2024, Theravance Biopharma And Mylan Entered Into A Settlement Agreement With Orbicular Pharmaceutical Technologies Private Limited Regarding Yupelri Inhalation Solution
Charles Gross
Friday, January 05, 2024
Theravance Biopharma shares are trading lower...
Benzinga Newsdesk
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Why Is Lung Disease Focused Theravance Biopharma Stock Trading Lower Today?
Vandana Singh
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
Theravance Biopharma Announces Results From P...
Benzinga Newsdesk
Thursday, December 28, 2023
Theravance Biopharma Said On Dec 26 Units, Mylan Ireland & Mylan Specialty Entered Settlement Agreement With Accord Healthcare Relating To Yupelri (Revefenacin) Inhalation Solution
Charles Gross
Thursday, November 16, 2023
Theravance Biopharma Will Present New Amprelo...
Benzinga Newsdesk
Monday, November 13, 2023
Viatris And Theravance Biopharma Announce Top...
Benzinga Newsdesk
Wednesday, November 08, 2023
Roblox, Under Armour, GoPro, Nuvei And Other Big Stocks Moving Higher On Wednesday
Lisa Levin
Tuesday, November 07, 2023
Theravance Biopharma Q3 2023 GAAP EPS $(0.17)...
Benzinga Newsdesk
Earnings Scheduled For November 7, 2023
Benzinga Insights
Monday, October 30, 2023
Theravance Biopharma Said Co's Units, Mylan Ireland Limited & Mylan Specialty L.P. Entered Settlement Deal With Teva Pharmaceuticals, Its Units Regarding Patent Litigation
Charles Gross
Friday, September 29, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Thursday, September 28, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Friday, September 15, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, August 28, 2023
Theravance Biopharma to Present New Ampreloxe...
Benzinga Newsdesk
Tuesday, August 08, 2023
HC Wainwright & Co. Reiterates Buy on Therava...
Benzinga Newsdesk
Monday, August 07, 2023
UPDATE: Theravance Biopharma Q2 Adj EPS $(0.1...
Benzinga Newsdesk
Theravance Biopharma Q2 Adj $(0.13) Beats $(0...
Benzinga Newsdesk
Earnings Scheduled For August 7, 2023
Benzinga Insights
Friday, August 04, 2023
Theravance Biopharma Earnings Preview
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch